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Bacteriophages encoding anti-CRISPR proteins
(Acrs) must cooperate to overcome phage resistance
mediated by the bacterial immune system CRISPR-
Cas, where the first phage blocks CRISPR-Cas
immunity in order to allow a second Acr phage to
successfully replicate. However, in nature, bacteria
are frequently not pre-immunized, and phage popu-
lations are often not clonal, exhibiting variations in
Acr presence and strength. We explored how inter-
actions between Acr phages and initially sensitive
bacteria evolve, both in the presence and absence
of competing phages lacking Acrs. We find that Acr
phages benefit ‘‘Acr-negative’’ phages by limiting
the evolution of CRISPR-based resistance and help-
ing Acr-negative phages to replicate on resistant
host sub-populations. These benefits depend on
the strength of CRISPR-Cas inhibitors and result in
strong Acrs providing smaller fitness advantages
than weaker ones when Acr phages compete with
Acr-negative phages. These results indicate that
different Acr types shape the evolutionary dynamics
and social interactions of phage populations in
natural communities.
INTRODUCTION
Viruses of bacteria (phages) are generally acknowledged to be
the most abundant entities on Earth and are thought to play a
major role in shaping microbial ecology and evolution (Koskella
and Brockhurst, 2014). CRISPR-Cas (clustered regularly inter-
spaced short palindromic repeats; CRISPR-associated) adap-
tive immune systems are widespread mechanisms that can
protect bacteria against phage infections (Hille et al., 2018;
Barrangou and Horvath, 2017; Koonin et al., 2017). These
adaptive immune systems insert short sequences derived
from invading phage genomes (spacers) into CRISPR loci on
the host genome. Transcription of these loci produces small
RNAs that associate with Cas proteins to form a ‘‘surveillance’’Cell Host & Microbe 27, 1–10, F
This is an open access article undcomplex that enables the bacterium to detect and cleave in-
fecting phage genomes carrying the cognate sequence (proto-
spacer). Evolution of CRISPR-based resistance can drive rapid
phage extinction (Van Houte et al., 2016), and in the face of this
immune system, some phages have therefore evolved to pro-
duce anti-CRISPR proteins (Acrs) that block the CRISPR sur-
veillance complex or the effector nucleases (Stanley and
Maxwell, 2018). These Acrs naturally vary in their potency to
suppress the host immune system, with some allowing phages
to efficiently bypass the CRISPR-Cas system (strong Acr) while
others are weaker inhibitors (Borges et al., 2018; Landsberger
et al., 2018). Crucially, in the case of the type I-F CRISPR-Cas
system, it has been shown that Acr phages need to work
together to infect hosts that are already CRISPR resistant
(Borges et al., 2018; Landsberger et al., 2018). Specifically,
while many infections of CRISPR-resistant hosts fail initially,
Acr phages leave behind an immunosuppressed cell, which is
presumably due to the expression of the acr gene prior to
the degradation of the phage genome mediated by Cas nucle-
ases (Stanley et al., 2019). These immunosuppressed hosts
can then be successfully exploited upon re-infection by other
Acr phages, thereby supporting the amplification of clonal
Acr phage populations (Borges et al., 2018; Landsberger
et al., 2018). This results in ecological dynamics where a den-
sity threshold needs to be reached in order for the Acr phage
population to amplify but their evolutionary dynamics remain
unexplored. Notably, bacteria will often not be naturally pre-
immunized but instead they will often be naive (i.e., not carrying
a targeting spacer) or primed (i.e., carrying a mismatched
spacer). Therefore, their ability to evolve CRISPR resistance
in the presence of Acr phages is likely to be a critical factor
that shapes phage-host interactions. Despite being the most
likely scenario in nature, interactions of Acr phages with initially
sensitive bacteria have not yet been studied, and how these
acr genes influence the evolutionary dynamics of bacterial
hosts is unknown. Moreover, with Acr delivery viewed as a
‘‘public good,’’ it has been speculated that Acr-mediated
immunosuppression could also protect other mobile genetic el-
ements (MGEs) against CRISPR-Cas immunity (Nussenzweig
and Marraffini, 2018). In this work, we investigate if and how
phages without Acr activity could ‘‘cheat’’ on Acr phages,
and how this impacts the evolutionary and population dy-
namics of the host and phages.ebruary 12, 2020 ª 2019 The Authors. Published by Elsevier Inc. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Acr Phages Limit the Acquisition of CRISPR Resistance
during Clonal Infection
To explore these questions, we first studied the individual inter-
actions between phages with (Acr-positive) or without (Acr-
negative) Acr activity and their host. We used the model system
of Pseudomonas aeruginosa wild-type (WT) strain PA14 that is
initially sensitive to the non-lysogenic phage DMS3vir, which
naturally encodes an Acr protein (AcrIE3) that is inactive against
the type I-F CRISPR-Cas system carried by PA14 (therefore
referred to as ‘‘Acr-negative phage’’). As ‘‘Acr-positive phages’’,
we used isogenic versions of DMS3vir that carry allelic replace-
ments of the acrIE3 gene with acrIF1 or acrIF4, which encode
respectively strong and weak inhibitors of the type I-F
CRISPR-Cas system of PA14 (Landsberger et al., 2018; Borges
et al., 2018).
WT P. aeruginosa PA14 or isogenic CRISPR knockout
(CRISPR-KO) strains were individually infected with phages
and serially passaged for 3 days. In both experiments, we
observed that the initially low phage-bacteria ratio (multiplicity
of infection [MOI]) rapidly reached high levels ( 103) at 1 day
post-infection (dpi) and subsequently declined (Figures 1A and
1B). These variations have important evolutionary conse-
quences since higher MOI tends to select bacteria that acquire
surface-based resistance over CRISPR-based resistance, while
low MOI favors the evolution of CRISPR-based resistance
(Westra et al., 2015). Interestingly, the population dynamics of
Acr-positive phages were not affected by the presence of a func-
tional CRISPR-Cas system in the host population (Figures 1A
and 1B), whereas Acr-negative phages were rapidly driven to
extinction byWT bacteria (Figure 1B). This is becauseWT bacte-
ria rapidly evolved CRISPR-based resistance against Acr-nega-
tive phages under these experimental conditions, as described
previously (Westra et al., 2015; Van Houte et al., 2016; Morley
et al., 2017) and confirmed by deep sequencing analysis of the
host CRISPR loci on day 3 post-infection (Figures 1C and 1D).
Of the two CRISPR arrays carried by WT PA14, CRISPR 2 con-
tains a spacer having 5 mismatches with gene 42 of DMS3vir,
which allows the ‘‘primed’’ acquisition of new targeting spacers
into both CRISPR arrays. As is typical of type I-F primed acqui-
sition, the phage sequences targeted by these new spacers (i.e.,
protospacers) clustered aroundDMS3vir gene 42, with upstream
and downstreamprotospacers located on the positive and nega-
tive strands, respectively (Figure 1E) (Westra et al., 2015). In
contrast, very low frequencies of ‘‘primed’’ spacer acquisition
were detected following infection with Acr-positive phages (Fig-
ures 1C–1E). As a result, the benefits of carrying a functional
adaptive CRISPR-Cas system were lost when bacteria were
exposed to Acr-positive phages, compared to Acr-negative
phages, even when the Acr was a weak inhibitor of CRISPR-
Cas (Figure 1F). Interestingly, our data showed that the two
Acr variants enhanced phage survival to comparable levels (Fig-
ure 1B), as they both efficiently reduced the proportion of
CRISPR-resistant hosts that evolved in the population (Fig-
ure 1G). These data suggest that Acr-positive phages may
benefit related Acr-negative phages in the community, not only
by immunosuppressing the CRISPR-resistant cells in the host
population, as previously suggested (Nussenzweig and Marraf-2 Cell Host & Microbe 27, 1–10, February 12, 2020fini, 2018), but also by limiting the evolution of this CRISPR-resis-
tant host sub-population in the first place.
Acr-Negative Phages Benefit from the Presence of Acr-
Positive Phages
To explore this hypothesis, we generated mixed phage popula-
tions (50:50 mix of Acr negative:Acr positive with strong or
weak Acr) to infect WT PA14 and monitored the relative fre-
quencies of eachphage type for 3 days. As a control, we first veri-
fied that in the absence of a functional CRISPR-Cas system, the
presence of Acr-positive phages had no impact on the amplifica-
tion of Acr-negative phages at 3 dpi (Figures 2A and S2A). More-
over, Acr-negative and Acr-positive phages had equal fitness to
one another (Figure 2B) and to a deletion mutant lacking the full
acr operon (Dacr) (Figure S1), suggesting that encoding an acr
operon is cost free under theseexperimental conditions. Interest-
ingly, when the host population carried a functional CRISPR-Cas
system, the presence of Acr-positive phages had a large impact
on Acr-negative phages, enabling them to avoid extinction after
3 days (Figure 2C). Looking at the compositions of phage popu-
lations over time, they shifted toward an increase in the propor-
tion of Acr-positive phages, which means that carrying a func-
tional acr gene that blocks the host immune system increases
the relative fitness of the phage (Figure 2D). Surprisingly, while
this increase in relative fitness was moderate for phages with
the strong Acr, it was much larger for phages encoding the
weakAcr (Figure 2D). Thesedata therefore indicate that encoding
a strong Acr activity is less advantageous than aweak one for Acr
phages, when they compete with Acr-negative phages.
Phageswith Strong Acr Reduce the Evolution of CRISPR
Resistance against Acr-Negative Phages
We wondered how Acr-positive phages enabled the survival of
Acr-negative phages and why this effect depended on Acr
strength.We hypothesized that it could result fromeither a reduc-
tion in the evolution of CRISPR resistance (see Figure 1), the
immunosuppression of CRISPR-resistant cells (Nussenzweig
and Marraffini, 2018), or both. To explore the first hypothesis,
we analyzed the evolution of CRISPR resistance over time when
hosts were infected with the mixed phage population. This
showed that, compared to infections with Acr-negative phages
alone, evolution of CRISPR-resistance was suppressed in the
presence of mixed phage populations and more strongly so
when the Acr was strong (Figures 3A and 3B). This could be due
to a stronger reduction of spacer acquisition (Vorontsova et al.,
2015) or to amore rapid depletion of hosts that evolved resistance
byphageswithstrongAcrs. In supportof this latterhypothesis,we
found that the strong Acr phages caused a stronger selection
against CRISPR-resistant bacteria with high levels of CRISPR
resistance (carrying 2 spacers ‘‘BIM-2sp’’) during competition
with surface mutant (Sm) bacteria that lack the phage receptor
and are therefore equally resistant against Acr-negative and
Acr-positive phages (Figure 3C). Importantly, the MOI pressure
chosen in this experiment falls within the range of MOIs observed
in Figures 1A and 1B. Collectively, these data show that Acr-pos-
itive phages can indirectly enhance the survival of Acr-negative
phages by limiting the evolution of CRISPR resistance, but they
do not exclude the possibility that generation of immunosup-
pressed cells also contributes to this survival effect.
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Figure 1. Impact of acr Genes on Phage Population Dynamics and Evolution of CRISPR Resistance during Infection of the Initially Sensitive
WT Host Population
(A and B) Phage (solid lines) and bacterial (dashed lines) populations dynamics upon individual infections of the CRISPR-KO (A) or theWT host by Acr-negative or
Acr-positive phages with different Acr (B).
(C) Frequency of spacer acquisition in CRISPR arrays 1 and 2 at 3 dpi in the evolved WT PA14 populations, as determined by deep sequencing.
(D) Frequencies of reads containing 1, 2, 3, 4, or 5 additional spacers.
(E) Protospacer distributions. Newly acquired spacers were extracted from read sequences and corresponding protospacers were mapped back to phage
genomes, on positive and negative strands. Observed distributions are consistent with primed spacer acquisition.
(F) Relative fitness of WT PA14 and CRISPR-KO strains at 3 dpi in the presence or absence of indicated phages at an initial MOI of 0.01. One-sample
t tests indicate significant differences from 1 for ‘‘Acr()’’ (p = 0.0004 and t5 = 8.3) and no significant differences for F1 (p = 0.42 and t5 = 0.87), F4 (p = 0.52 and t5 =
0.52), and No phage control (p = 0.61 and t5 = 0.54).
(G) Distribution of phage-resistancemechanisms that evolved at 3 dpi (based on analysis of 24 clones per replicate). CRISPR-Cas, detection of additional spacers
assessed by PCR; Sm, surface mutant; Und., undetermined. These are clones for which the results were inconclusive.
In all panels, data shown are the mean of 6 biological replicates per treatment. Shaded areas and error bars represent 95% confidence intervals (CIs). F1,
DMS3vir-acrIF1; F4, DMS3vir-acrIF4; and Acr(), DMS3vir.
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Figure 2. Acr-Positive Phages Benefit Acr-Negative Phages
(A) Amplification of Acr-negative phage population between T = 0 and 3 dpi in the absence (individual) or in the presence (mixed) of indicated Acr-positive phages.
(B) Relative fitness of Acr-positive phages during competition on the CRISPR-KO strain. See also Figure S1.
(C) Amplification of Acr-negative phage population between T = 0 and 3 dpi in the absence (individual) or in the presence (mixed) of indicated Acr-positive phages.
(D) Relative fitness of Acr-positive phages during competition on the WT strain. Asterisks indicate statistically significant differences. Two-tailed t tests (C) in-
dividual versus mixed F1: p < 0.0001 and t10 = 11; individual versus mixed F4: p = 0.0003 and t10 = 5.49; andmixed F1 versus mixed F4: p = 0.0011 and t10 = 4.56.
One-tailed t tests at 3 dpi (D) F1:Acr(): p = 0.013 and t5 = 3.78 and F4:Acr(): p = 0.0003 and t5 = 8.63.
In all panels, data shown are the mean of 6 biological replicates per treatment and error bars represent a 95% CI.
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Negative Phages to Infect CRISPR-Resistant Hosts
To test this second hypothesis, we examined whether Acr-nega-
tive phages were able to amplify on CRISPR-resistant hosts in
the presence of Acr-positive phages and how this depended
on the level of host resistance. Acr-positive phages can amplify
on CRISPR-resistant hosts but only under conditions where
sequential infections are likely to occur, i.e., when the MOI is
above a certain value. Moreover, this critical MOI threshold de-
pends both on the strength of the Acr and on the level of host
resistance, which increases with the number of targeting
spacers (Figures S2B and S2C) (Landsberger et al., 2018). In
contrast, Acr-negative phages on their own can never reproduce
on a pre-immunized host population (Figures S2B–S2D), unless
they carry ‘‘escape’’ mutations in their protospacer (Figures4 Cell Host & Microbe 27, 1–10, February 12, 2020S2C–S2E, pink circled dots), but these are less likely to arise
when the host carries multiple spacers (BIM-2sp, Figure S2D).
We therefore infected pre-immunized bacteria carrying one
(BIM-1sp) or two (BIM-2sp) targeting spacers with 50:50 mix-
tures of Acr-positive and Acr-negative phages. We observed
that Acr-negative phages became able to multiply on CRISPR-
resistant hosts in the presence of phages encoding the strong
Acr when the initial MOI was above 0.1 (Figures 4A and 4B), indi-
cating that such exploitation of strong Acr may occur when
sequential infections are likely. In contrast, this was never
observed in the presence of phages encoding a weak Acr (Fig-
ures 4C and 4D), even when the MOI was high enough to allow
amplification of the Acr-positive phages (i.e., ensuring that
sequential infections, or even co-infections, occur in these con-
ditions). We verified that all Acr-negative phages that amplified
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Figure 3. Presence of Strong Acr Phages Strongly Reduces the Evolution of CRISPR Resistance
(A and B) Proportion of WT hosts evolving CRISPR-based resistance over time upon individual (A) or mixed infections (B) (n = 144; 24 clones tested in each of 6
independent infections).
(C) Relative fitness of bacteria with CRISPR resistance (BIM-2sp, 2 targeting spacers) and surface mutant (Sm) in the presence of indicated phages (MOI ~ 25).
Significant differences from 1 (one-tailed t tests: F1, p < 0.0001 and t5 = 2189 and F4, p < 0.0001 and t5 = 319) or in-between values (two-tailed t test: F1 versus F4,
p = 0.0003 and t10 = 5.35) are indicated.
In all panels, data shown are the mean of 6 biological replicates per treatment and error bars represent a 95% CI.
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https://doi.org/10.1016/j.chom.2019.12.004after 24 h in the presence of the strong Acr phage (green-circled
dots, Figures 4A and 4B) were still sensitive to CRISPR immunity
(Figures 4E and 4F) and had not acquired escape point muta-
tions (Figures S3A and S3C), whereas those that amplified in
the presence of theweak Acr phage (pink circled dots, Figure 4C)
had acquired escape mutations that made them insensitive to
CRISPR targeting (Figures 4E and S3B). Even though they did
not amplify, WT Acr-negative phages could still benefit from
the presence of weak Acr phages, as demonstrated by their
reduced rate of decline (mild protective effect, compare black
lines in Figures S2D and 4D). Altogether, these results show
that Acr-negative phages may benefit from the presence of
Acr-positive phages through two mechanisms. First, the Acr-
positive phages can indirectly protect Acr-negative phages
from CRISPR degradation by limiting the evolution of CRISPR-
resistance, and second, they can directly facilitate the replication
of Acr-negative phages by producing immunosuppressed hosts.A Model to Understand How Variations in Acr
Biochemistry Shape the Population and Evolutionary
Dynamics of Bacteria and Phages
Next, to understand why strong and weak Acrs differ in the ben-
efits they share with the wider phage community, we refined our
previously published mathematical model (Landsberger et al.,
2018), which allows us to break down different components of
Acr activity and track the dynamics of each member of the com-
munity (i.e., Acr-negative andAcr-positive phages aswell as sen-
sitive, immunosuppressed, and CRISPR-resistant bacteria). To
match with our experimental system, this model assumes that
bacteria are initially sensitive (W) but can evolve CRISPR-based
resistance upon phage infection (Figure 5A). Infection of a
CRISPR-resistant bacterium (R) by an Acr-positive phage can
lead either to cell lysis (V) with probability4 (which leads to deple-
tion of the CRISPR-resistant sub-population) or result in a failed
infection that leaves the host in an immunosuppressed state (S)Cell Host & Microbe 27, 1–10, February 12, 2020 5
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https://doi.org/10.1016/j.chom.2019.12.004(which provides an opportunity for other phages to exploit immu-
nosuppressed cells). Immunosuppressed cells revert back to the
resistant state after a certain duration g1. Hence,4 and g1 both
measure the ‘‘strength’’ of an Acr but likely reflect different
biochemical properties, such as the affinity for the Cas protein it
targets and the stability of the Acr itself or that of the Acr-Cas
interaction. Experimental estimates of the efficiency of centers
of infection (ECOI), as a proxy for 4, show that the probability to
lyse a CRISPR-resistant host is higher for the AcrIF1 phage (Fig-
ureS4). Therefore, this suggests that the higher strengthof AcrIF1
is (at least partly) explained by a higher value of 4. To further
explore the respective influences of 4 and g1 on the phage
and host population dynamics (if any) during infection of initially
sensitive bacteria, we can vary both parameters independently
in our simulations (see STAR Methods for a full description of
themodel). Asacontrol,wefirst confirmed thatmodel predictions
during infections with clonal phage populations were consistent
with our empirical data. Indeed, themodel predicts that individual
infection of initially sensitive bacteria with Acr-negative phages
leads to rapid phage extinction due to the evolution of CRISPR-
based resistance (Figure S5A), whereas Acr-positive phages
avoid extinction across a large range of4 and g1 values (Figures
S5B–S5G consistent with Figures 1A and 1B, i.e., no differences
between Acr variants in this context). Next, we explored the ef-
fects of 4 and g1 during infections of WT bacteria with mixed
phage populations and found that both Acr-positive and Acr-
negative phages avoid extinction in this context (Figure 5B).6 Cell Host & Microbe 27, 1–10, February 12, 2020Mathematical Modeling Predicts
that Acrs Differ in Their Ability to
Generate Lasting
Immunosuppression
Given that phages encoding AcrIF1 have
higher ECOI and efficiency of plaquing
(EOP) values than those encoding AcrIF4
(Figure S4) (Landsberger et al., 2018), we
first explored how manipulating 4 im-
pacts the bacteria and phage population
dynamics. Interestingly, we found thatincreasing the value of 4 resulted in an increased fitness advan-
tage of the Acr-positive phage over the Acr-negative phages
(Figure 5C). This intuitively makes sense since a high value of 4
means a reduced frequency of failed infections (and therefore
a lower proportion of immunosuppressed cells), which limits
the opportunities for Acr-negative phages to reproduce. How-
ever, our experiments have shown that AcrIF4-phages (with
the lowest 4 value) had the highest fitness advantage over Acr-
negative phages (Figure 2D). Therefore, the manipulation of 4
alone, as a simulation of varying Acr strength, cannot explain
our experimental data. By contrast, when we manipulated the
value of g1, we found that a longer-lasting immunosuppression
resulted in a smaller fitness advantage during direct competi-
tions with Acr-negative phages (Figure 5D). Hence, assuming
that AcrIF1-phages not only lyse CRISPR-resistant cells more
efficiently (i.e., higher value of 4) but also induce longer periods
of immunosuppression when infections fail (i.e., a higher value of
g1) allows us to obtain a good fit between the experimental and
simulation data. These high g1 values can explain why the
AcrIF1 phages have a lower fitness advantage over Acr-negative
phages compared to AcrIF4 phages (i.e., Figure 5D consistent
with Figure 2D). In addition, when increasing the value of g1,
the model predicts that (1) the sub-population of CRISPR-resis-
tant bacteria is depleted more rapidly (Figures S6D–S6F black
lines, consistent with Figure 3B) and (2) greater numbers of im-
munosuppressed cells accumulate, which can be exploited by
Acr-negative phages (Figures S6D–S6F orange lines, consistent
A
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Figure 5. Modeling of Different Acr
Strengths and Their Impact on Acr-Nega-
tive Phages
(A) Infection model of the Acr-positive phage (see
details of the model in the STAR Methods). The
parameter H(t) = aV(t) refers to the rate at which
bacteria are infected by free phage particles, A is
the probability that bacteria acquire CRISPR-
based resistance.
(B) Bacteria and phage population dynamics upon
infection of initially sensitive hosts (dashed line)
with an equal mix of 100 Acr-negative (blue line)
and 100 Acr-positive phages (red line, 4 = 0.3 and
g1 = 1). Initially sensitive bacteria evolve
CRISPR-resistance (solid black line), which in turn
can become immunosuppressed upon infection
by Acr-positive phages (orange line).
(C and D) Effect of 4 (C) and g1 (D) on the ratio of
Acr-positive and Acr-negative phages following
infection of sensitive bacteria. Other parameter
values: a = 0.001, A = 0.2, B = 5, and r = 0.5.
See also Figures S4, S5, and S6.
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https://doi.org/10.1016/j.chom.2019.12.004with Figures 4A and 4B). Therefore, our results suggest that the
observed differences between AcrIF1 and AcrIF4 may be ex-
plained by significant differences both in the ability to lyse resis-
tant cells (4 in our model) and in the lifetime of immunosuppres-
sion (g1 in our model).
DISCUSSION
In summary, our results show that Acr-negative phages can
benefit from the presence of Acr-positive phages to infect bac-
teria carrying type I-F CRISPR-Cas systems. In nature, the
infection dynamics of a mixed population of Acr-positive and
Acr-negative phages will also depend on the level of cross-
reactivity of the CRISPR-Cas immune system against the
competing phages. A recent study analyzing the CRISPR ar-
rays from >700 P. aeruginosa genomes has shown that a given
spacer usually provides such cross-reactivity, as it typically
matches several viruses (e.g., 2.75 viruses on average), which,
in general, are genetically close and co-occur in the same
ecological niche (and hence are likely to compete for the
same hosts), but some spacers have also been found to pro-
vide cross-reactive immunity against distantly related viruses
(England et al., 2018).
Second, the model and data presented here also show that
during competitive infections, the strength of the AcrIF protein
determines to what extent its benefits are ‘‘shared’’ with other
phages. Notably, the shared benefits provided by strong AcrIF
proteins result from two effects. First, strong Acr phages
deplete the pool of CRISPR-resistant hosts more rapidly than
weak Acr phages, which is somewhat analogous to the way
antibiotic-resistant bacteria can support growth of sensitive
species by detoxifying the environment (Dugatkin et al., 2003,
2005; Medaney et al., 2016). Then, they enable Acr-negative
phages to exploit CRISPR-resistant hosts through immunosup-
pression, whereas weak Acrs do not. The net result of these ef-
fects is that a strong Acr activity is less advantageous than aweak one for an Acr-positive phage when competing with
Acr-negative phages. This may be important especially during
the early evolution of new acr genes since those that are
weak would invade the phage population more rapidly
compared to strong ones. However, this could be a transient ef-
fect since in the longer term—when phages with different Acrs
have emerged and compete against each other—weak Acrs
no longer provide the greatest fitness benefit. Specifically,
direct competition between phages with strong AcrIF1 and
weak AcrIF4 showed that strong Acr phages were favored
when the bacterial host population was already CRISPR-resis-
tant, whereas the two Acr phages were found to be equally fit
when the host population was initially phage sensitive (Figure 6).
The fact that pre-existing CRISPR immunity is relatively rare,
along with the non-transitivity of the competitive interactions,
may therefore contribute to the coexistence of strong and
weak Acr phages in nature.
Our mathematical prediction that AcrIF1 induces longer dura-
tion of immunosuppression (compared with AcrIF4) is consis-
tent with data showing that it binds the Csy surveillance com-
plex with higher affinity and slower off rates than AcrIF4
(Borges et al., 2018). This parameter g1 is critical to explain
the smaller fitness benefit of AcrIF1 during competition with
Acr-negative phages and effectively determines the potential
for Acr ‘‘public goods’’ production: the greater the g1, the
more immunosuppressed cells are generated in the population
and the greater the opportunity for other phages to exploit these
immunosuppressed cells. This is analogous to the production of
iron scavenging molecules, communication signals, and viru-
lence factors, which are produced by few individuals but can
benefit the whole population (Diggle et al., 2007; Griffin et al.,
2004; Raymond et al., 2012). However, unlike these examples
of altruistic cooperation, the production of Acr proteins surpris-
ingly appears to be cost free in our system (Figure S1)—which
may be due to the tight regulation of acr expression by the
anti-CRISPR-associated protein Aca (Birkholz et al., 2019;Cell Host & Microbe 27, 1–10, February 12, 2020 7
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Figure 6. Phages with Strong Acr Do Not
Have a Fitness Advantage over Phages
with Weak Acr When Bacteria Are Initially
Sensitive
(A–C) Population dynamics of weak and strong
Acr-positive phages during mixed infection of (A)
CRISPR-KO, (B) initially sensitive (WT), or (C)
CRISPR-resistant (BIM-2sp) hosts.
(D) Fitness values of strong AcrIF1-phage relative
to that of weak AcrIF4-phage were calculated on
day 3.
Graphs show individual data (A)–(C) or means (D)
from 6 independent biological replicates. Error
bars indicate a 95% CI.
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https://doi.org/10.1016/j.chom.2019.12.004Stanley et al., 2019). That said, our experimental data do not
rule out the possibility that encoding an acr operon carries a
cost for phages in natural environments. Apart from direct costs
due to necessary high levels of gene expression (Mahmouda-
badi et al., 2017), there may also be a cost of opportunity as
the overall genome size of the phage is constrained by the
space in the phage capsid.
If carrying acr genes is indeed costly, then the stability of
phage populations that evolve stronger ‘‘cooperative’’ Acr
(high g1) may be impaired by the invasion of Acr negative
‘‘cheats’’ that do not contribute to public good production
while still sharing the benefits (Hamilton, 1964). The factor 4,
on the other hand, may be best described as a selfish trait
that reflects the probability that the first phage will neutralize
CRISPR-Cas immunity and lyse the host. It therefore depends
on the affinity of the Acr for the Cas interference complexes,
and its value is constrained by the biochemical and biophys-
ical properties of the Acr. Another way for the phage to evolve
a stronger ‘‘selfish’’ Acr (high 4) is, for instance, to increase
the production of Acr. However, this may be particularly costly
because of limitations in the resource and energy availability
in the cell. Note that in our model system, the strong and
weak Acr phages are isogenic (except for the acr coding
sequence), therefore the differences in 4 are likely not due
to differences in acr transcription. Overall, our study suggests
that the composition of the phage population (i.e., whether
clonal or mixed) is likely to be a key driver of differences in
4 and g1: higher 4 and/or lower g1 may be favored during
competition while lower 4 and/or higher g1 will be favored
by kin selection. In addition, one can speculate that mutations
in acr genes may have pleiotropic effects (e.g., the ability8 Cell Host & Microbe 27, 1–10, February 12, 2020to induce lasting immunosuppression
might be a by-product of the strong in-
hibition of CRISPR-Cas surveillance
complexes), and therefore 4 and g1
cannot evolve independently (Dos San-
tos et al., 2018).
The effects of encoding strong or
weak Acrs during competition with other
MGEs will further depend on their trans-
mission mode, such as their ability to
transmit only horizontally (as in the
current study) or both horizontally and
vertically (as is the case for temperatephages and conjugative plasmids). For example, if the
CRISPR-Cas system of the host targets the Acr-MGE, vertical
transmission may be associated with selection for high g1
but weaken selection for 4. However, it is also possible that
an active host immune system contributes to the fitness of a
vertically transmitting Acr-MGE by providing protection against
other parasitic MGEs, in which case weaker Acr activities might
be positively selected. Future experiments will be critical to un-
derstand if and how interactions between the ecological context
and the life history traits of MGEs impacts the evolution of
strong or weak Acrs.
Finally, similar approaches aiming at understanding the
ecological and evolutionary parameters that influence the
selection for type II Acrs may be valuable for biotechnological
applications. Interestingly, Acrs specific to Cas9 have also
been reported to have variable strengths, e.g., AcrIIC2Nme is
less potent than AcrIIC1Nme in inhibiting Neisseria meningitidis
Nme1Cas9 (Thavalingam et al., 2019) and different AcrIIA pro-
teins targeting Streptococcus pyogenes SpyCas9 demonstrated
variable efficiencies in inhibiting CRISPR-based interference
(CRISPRi) or activation (CRISPRa) in eukaryotic cells (Nakamura
et al., 2019).
Future single cell analyses, as well as studies providing deeper
insight into the biochemical bases of Acr-Cas interactions and
accurate experimental measures of g1 and 4, will be necessary
to further validate and refine the model presented here. This will
be fundamental to fully understand the evolutionary drivers and
consequences of acr genes with different strengths and their
implications for the wider phage community and other MGEs
that spread in the face of bacteria with CRISPR-Cas immune
systems.
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DMS3vir Cady et al., 2012 N/A
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DMS3vir-acrIF4 Landsberger et al., 2018 N/A
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Sequence data European Nucleotide Archive ENA: PRJEB29041
Raw data Mendeley Data https://doi.org/10.17632/g3ffrjz4dy.1
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pHERD20T Davidson lab GenBank: EU603324.1
Software and Algorithms
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Samtools (1.3.1) Li et al., 2009 http://samtools.sourceforge.net/
R (version 3.5.1) R Core Team, 2014 https://www.R-project.org/
Primer Express 3.0.1 Thermo Fisher Scientific Cat#4363991
QuantStudio Real-Time PCR Software v1.3 Thermo Fisher Scientific
Applied Biosystems
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software.html
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Bacteria
The wild-type strain UCBPP-PA14 of Pseudomonas aeruginosa (WT), the derived strains carrying 1 or 2 spacers targeting phage
DMS3vir (BIM-1sp and BIM-2sp, respectively), the strain UCBPP-PA14 csy3::lacZ (CRISPR-KO) which CRISPR-Cas system is
not functional and the derived surface mutant (Sm) strain were used throughout this study and are described in Landsberger
et al. (2018) and references therein. Escherichia coli strain DH5awas used to construct and amplify guide-RNA expression plasmids,
which were subsequently transformed into P. aeruginosa PAO1::spycas9 carrying the cas9 gene of Streptococcus pyogenes under
the control of an arabinose-inducible promoter (described in Mendoza et al., 2019).
Bacteria were routinely cultured at 37C either in Lysogeny Broth (LB) or M9 minimal medium (22 mM Na2HPO4; 22 mM KH2PO4;
8.6 mM NaCl; 20 mM NH4Cl; 1 mMMgSO4; 0.1 mM CaCl2) supplemented with 0.2% glucose. When appropriate (for plasmids
maintenance and expression), LB was supplemented with either 100 mg.ml1 ampicillin (E. coli DH5a) or 50 mg.ml1 gentamicin
(PAO1::spycas9) and 0.1 % (w/v) arabinose.
Phages
TheMu-like virulent phage DMS3vir was used throughout this work (described in Cady et al. (2012)). DMS3vir infects strains PAO1::
spycas9, PA14 WT and CRISPR-KO, but not BIM-1sp and BIM-2sp. Phage isogenic variants carrying anti-CRISPR genes, namely
DMS3vir-acrIF1 andDMS3vir-acrIF4, were described previously (Landsberger et al., 2018; VanHoute et al., 2016). PhageD3112 (Kry-
lov et al., 1980;Wang et al., 2004), genetically distinct fromDMS3vir but using the same bacterial receptor (pilus), was used to analyse
the evolution of bacterial resistance. Phage stocks were obtained from lysates prepared on PA14 CRISPR-KO and stored at 4C.
METHOD DETAILS
Individual Phage Infection Assays
Glass vials containing 3 ml of M9 + 0.2% glucose medium were inoculated with approximately 107 colony forming units (CFUs) from
fresh overnight cultures of WT or CRISPR-KO strains and infected with either phage DMS3vir, DMS3vir-acrIF1 or DMS3vir-acrIF4 at
an initial multiplicity of infection (MOI) of 0.01. Infected cultures were then incubated at 37C under agitation and transferred daily
(1:100 dilution) into fresh medium. Each experiment was performed in 6 replicates. Phage and bacterial concentrations were as-
sessed every day for 3 days by spot assays and cell plating, respectively.e2 Cell Host & Microbe 27, 1–10.e1–e6, February 12, 2020
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High-Throughput Sequencing of CRISPR Arrays
Total DNA was extracted from samples of WT bacterial cultures individually infected with either DMS3vir, DMS3vir-acrIF1 or
DMS3vir-acrIF4, at 3 days post infection (dpi), using QIAamp DNAMini kit (Qiagen), according to manufacturer’s instructions. Quality
and concentration of DNA samples were verified on a 0.5% agarose gel and assessed by Qubit. To generate amplicons for
sequencing, the following primers were used:
5’-GGCGCTGGAGCCCTTGGGGCTTGG and 5’-GCGGCTGCCGGTGGTAGCGGGTG for CRISPR array 1;
50-GCTCGACTACTACAACGTCCGGC and 50-GGGTTTCTGGCGGGAAAAACTCGG for CRISPR array 2.
Libraries were prepared by the Centre for Genomic Research (University of Liverpool, UK) and 23250 bp paired-end reads gener-
ated on an Illumina MiSeq platform.
Sequenced reads were trimmed for the presence of Illumina adapter sequences using Cutadapt version 1.2.1 (Martin, 2011).
The option -O 3 was used, so the 30 end of any reads which match the adapter sequence for 3 bp or more are trimmed. Reads
were further trimmed using Sickle version 1.2 (https://github.com/najoshi/sickle) with a minimum window quality score of 20.
Reads shorter than 20 bp after trimming were removed. Reads were merged with Flash version 1.2.11 (Magoc and Salzberg
2011) and a further 5 bases were trimmed from the 50 end of each read, following additional quality checks. The resulting
read length distributions were determined directly with an Awk expression. Merged reads were then processed using the Qiime2
platform (version 2018.2). Additional quality filtering was done using the default settings based on sequence quality scores (min-
imum phred score = 4, maximum number of consecutive low scores = 3, minimum length of sequence after filtering = 75% of the
original read). Sequences were dereplicated and clustered at 99% similarity using Vsearch (Rognes et al., 2016). Spacers from
the clustered reads were predicted using a modified version of CRISPRDetect (Biswas et al., 2016) and extracted using a Perl
script. Spacers were mapped to the DMS3vir genome (based on NCBI RefSeq: NC_008717 edited to match the sequence
described in Cady et al., 2012) using bwa (version 0.7.17) and samtools (1.3.1). The resulting BAM files were plotted in R (version
3.5.1).
Phenotypic Analyses
To determine which phage-resistance mechanisms evolved in WT bacterial populations, either upon individual or mixed-infections,
24 individual colonies (per replicate) were picked and grown in 200 ml of LB broth for 3h at 37Cand 5 ml of these cultures were spotted
on LB agar plates, in triplicate. Two microliters (approximately 105 plaque forming units (PFUs)) of either the ancestral phage (i.e.
DMS3vir, DMS3vir-acrIF1 or DMS3vir-acrIF4), an alternative phage D3112 or LB broth (negative control) were dropped on top of bac-
terial spots. These phenotypic assays allowed to determine whether a given clone was (i) phage-sensitive (lysed by both the ancestral
and alternative phages), (ii) resistant through surface modification (resistant to both ancestral and alternative phages) or (iii) resistant
through CRISPR-immunity (resistant to ancestral phage, sensitive to alternative phage). For the latter, CRISPR-resistance
was further confirmed by testing clones for acquisition of spacers by PCR using primers 50-CTAAGCCTTGTACGAAGTCTC and
50-CGCCGAAGGCCAGCGCGCCGGTG (for CRISPR array 1) and 50-GCCGTCCAGAAGTCACCACCCG and 50-TCAGCAAGTTAC
GAGACCTCG (for CRISPR array 2).
Bacterial Competition Experiments
Glass vials with 6 ml M9 + 0.2% glucose were inoculated with approximately 2.107 CFUs from a 1:1 mixture of overnight cultures
(grown in M9 medium + 0.2% glucose) either of phage-resistant strains BIM-2sp and Sm, or of phage-sensitive strains WT and
CRISPR-KO. Phages (DMS3vir, DMS3vir-acrIF1 or DMS3vir-acrIF4) were then added to each glass vial at a MOI of 0.01 (for the
WT x CRISPR-KO competition) or 25 (for the BIM-2sp x Sm competition). Control competition experiments in the absence of phages
were performed in parallel. All competition experiments were performed in 6 replicates. Mixed-cultures were transferred daily (1:100
dilution) into fresh medium. At 0, 1 and 3 days after the start of the experiment, samples were taken and cells were serially diluted in
M9medium and plated on LB agar supplemented with 50 mg.ml1 X-gal (to allow discrimination betweenWT or BIM-2sp (white) and
CRISPR-KO or Sm (blue) strains). Phage concentrations were also monitored at 0, 1 and 3 days using spot assays. Relative fre-
quencies (fractions) of competing strains were determined through colony numbers and used to calculate the relative fitness accord-
ing to formula below:
Relative fitness WTt = x =
ðFraction WTt = x Þ3 ð1 Fraction WTt =0Þ
ðFraction WTt = 0 Þ3 ð1 Fraction WTt = xÞ
Phage Competition Experiments
Mixed Phage Infections
Phage mixtures (1:1) of either DMS3vir-acrIF1:DMS3vir, DMS3vir:DMS3vir-acrIF4 or DMS3vir-acrIF1:DMS3vir-acrIF4 were used to
infect fresh cultures of either CRISPR-KO, WT, BIM-1sp or BIM-2sp (approx. 4.106 CFU.ml-1 in 6 mL of M9 + 0.2% glucose medium,
verified by cell plating), each in 6 replicates. Mixed-infections were carried out at a MOI of 0.02 on CRISPR-KO and WT strains, at
MOIs of0.01, 0.1 and 1 on BIM-1sp and at MOIs of1 and 50 on BIM-2sp. Cultures were transferred daily (1:100 dilution) into fresh
medium and samples were taken at 0, 1, 2 and 3 dpi to monitor the concentrations of each phage population. Upon chloroformCell Host & Microbe 27, 1–10.e1–e6, February 12, 2020 e3
Please cite this article in press as: Chevallereau et al., Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages, Cell Host & Microbe (2019),
https://doi.org/10.1016/j.chom.2019.12.004extraction (addition of 1:10 v/v chloroform to cultures, vortex for 30 s and pellet cell debris and chloroform at 4C), total phage sam-
ples were serially diluted in M9medium and spot assays were performed on PAO1::spycas9 indicator strains (see below for descrip-
tion). This allowed to distinguish competing phages and hence to determine the concentrations of each type of phage genotype in the
population.
Construction of PAO1::spycas9 Indicator Strains
The pJB1 plasmid (described inMendoza et al., 2019) harbours a BsaI site for insertion of a desired spacer sequence, a crRNA repeat
sequence and a tracrRNA sequence. Upon digestionwith BsaI, annealed and phosphorylated oligonucleotides containing the spacer
sequence of interest flanked by BsaI sites were ligated into pJB1. Strain PAO1::spycas9was transformed with pJB1 expression vec-
tors by electroporation. Briefly, an indicator strain PAO1::spycas9 carrying a pJB1 expression vector produces a crRNA::tracrRNA-
loaded SpyCas9 protein that targets a protospacer complementary to the spacer cloned into the pJB1 vector. As a result, a phage
carrying this protospacer cannot produce plaques on that indicator strain. All indicator strains (and corresponding spacer sequences)
are listed in Table S1.
Determination of Relative Fitness of Competing Phages by qPCR
Relative frequencies of each phage in co-cultures were measured at 0, 1, 2 and 3 dpi with qPCR (using specific primer sets)
allowing the calculation of phages’ relative fitness. Primer pairs were designed using Primer Express 3.0.1 and are listed in Ta-
ble S2. Each primer pair was tested against the 2 other phages and non-specific amplification could not be detected. Total
phage samples obtained upon chloroform extractions were used as templates. Each qPCR reaction was prepared following
manufacturer’s recommendations and composed of 7.5 ml Brilliant III Ultra-Fast SYBR Green QPCR Master Mix (Agilent Tech-
nologies, Santa Clara, CA, United States of America), 0.3 ml of provided reference dye (freshly diluted 1:50 in PCR-grade water,
final concentration 300 nM), 1.5-ml primer pair (4.5mM each), 0.15-ml bovine serum albumin (20 mg.ml-1), 3.75 ml undiluted phage
sample (or standard phage solutions or water), and PCR-grade water to a total volume of 15 ml. For each primer set, standard
reactions (six ten-fold dilutions of pure matching-phage stock solutions (103 to 108 PFU.ml1) in PCR-grade water) and negative
controls (either water or 108 PFUs of non-matching phages) were systematically included and performed in triplicate. Two qPCR
reactions were performed on each sample (each reaction being specific to one or the other phage in the sample). All samples
were run at the same time, on a 384-well plate, to avoid between-run variations and to ensure that all samples were analysed
against the same standards curves. The qPCR program was 95C for 10 min, followed by 40 cycles of 95C for 15 s and 60C
for 20 s and was run on QuantStudio 7 Flex Real-Time PCR System (Applied Biosystems). Provided that the efficiencies of
the reactions were between 90% and 110%, the threshold cycle (CT) was used to calculate the quantity of the targeted phage in
each sample (deduced from standard curves, computed by QuantStudio Real-Time PCR Software v1.3). Average quantities
(Q) - for the 6 biological replicates of each competition – were then used to calculate phage relative frequencies (fraction, see
below), allowing to further calculate phage relative fitness (same equation as described in the bacterial competition sec-
tion above).
Fraction phage 1 =
Qphage1
Qphage1 +Qphage2
Fitness Costs Associated with acr Operon
Potential fitness costs associated with acr operon were assessed by competing a phage deletion mutant lacking the entire acr
operon (i.e. promoter, Acr coding sequence and acaI gene) with an isogenic phage carrying the operon (with AcrIE3 or AcrIF1 or
AcrIF4 coding sequence) in absence of selection (i.e. on CRISPR-KO host). Phage competition experiments were performed as
indicated above.
Construction of Phage Deletion Mutants
Recombination cassettes containing in-frame deletions of the acr operon bordered by  500–650 bp flanking regions at each side
were generated and inserted into the shuttle vector pHERD20T using a Gibson assembly protocol (as described in Borges et al.,
2018). The ‘up’ and ‘down’ fragments of the cassette were amplified from phage DMS3vir-acrIE3 using the following primers (respec-
tively): 50-TACCCATGGGATCTGATAAGAATTCGAGCTATCCGTCTGCGCGGCGAGATA (forward), 50- CGTGTAGCGCGTTTGCGG
GCGGATCAGGTGAAGGCACAGTGTGCCGCTTGTC (reverse) and 50-TCACCTGATCCGCCCGCAAAC (forward), 50-GACGGCCA
GTGCCAAGCTTGCATGCCTGCACATTCGAAATCGAGGAAGCGGC (reverse). The PA14 CRIPSR-KO strain was transformed
with this recombination vector by electroporation and transformants were infected with DMS3 to generate recombinant temperate
phages (as described in Borges et al., 2018). The resulting DMS3 deletion mutants were essayed for their inability to interfere with
CRISPR-Cas targeting, and the genomic region normally enclosing the acr operon was PCR amplified and sequenced to confirm
correct recombination. CRISPR-KO lysogens of DMS3 deletion mutants were used to truncate gene DMS3-1 (c-repressor) as
described in Cady et al. (2012), yielding recombinant lytic phages carrying deletion of acr operon (referred to as Dacr).
Efficiency of Centre of Infection (ECOI) Assays
Overnight cultures of CRISPR-KO and BIM-1sp were OD-adjusted and 20 ml were used to inoculate 180 ml of fresh M9 + 0.2%
glucose in a 96-well plate. After 2h-growth at 37C, 20-ml aliquots were sampled to measure uninfected bacterial concentration
and phages (DMS3vir, DMS3vir-acrIF1 or DMS3vir-acrIF4) were added at MOI of1 and incubated for 30 min (adsorption). Cultures
were thenwashed three timeswithM9 salts to remove free phages, serial diluted and 5 ml were spotted onto LB agar (concentration ofe4 Cell Host & Microbe 27, 1–10.e1–e6, February 12, 2020
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infection of a single pre-adsorbed cell (i.e. a centre of infection). ECOI was calculated as follows:
EOIC =
½Centres of Infection
½Pre adsorbed cellsxMOI
By normalizing the number of successful infections on a CRISPR-resistant host by that on CRISPR-KO host, this assay provides a
direct measure of the success rate of the first infection of a CRISPR-resistant host by a phage, which reflects the value of 4.
4z
ECOIBIM1sp
ECOICRISPRKO
Mathematical Modelling
We extended our previously described epidemiological model (Landsberger et al., 2018), to model the population dynamics of Acr-
phages in an initially sensitive host population that can evolve CRISPR resistance. All simulations were performed in the software
Mathematica version 11.2.
Bacteria may either be sensitive (the density of these bacteria is denotedW(t)), or may have evolved CRISPR-resistance after the
incorporation of a spacer targeting the phage (the density of these bacteria is noted R(t)), or may be in an immunosuppressed state
(the density of these bacteria is noted S(t)).
Initially the host population is homogeneous, consisting exclusively of sensitive bacteria. Bacteria grow at a maximal rate
r, but this growth is limited by the density of bacteria (where k measures the intensity of density dependence), and bacteria
die with mortality rate m. At t = 0, an inoculum of free Acr-positive phages with density V1(0) is introduced in the host population,
or an inoculum of Acr-negative phages with density V2(0), or an equal mix of Acr-positive and Acr-negative phages, such that
V1(0) = V2(0).
All free phage particles adsorb to the bacteria at a rate a. When a free phage adsorbs to a sensitive bacterium, two outcomes are
possible:
(i) with probability 1  A, the phage lyses the host, leading to the release of B new phage particles
(ii) with probability A, the bacterium acquires CRISPR-based resistance, leading to the destruction of the phage genome
When an Acr-negative phage particle adsorbs to a CRISPR-resistant bacterium, its genome is destroyed. When an Acr-positive
phage adsorbs to a CRISPR-resistant bacterium, three outcomes are possible, as described in our previous model (Landsberger
et al., 2018):
(i) with probability r, the Acr-positive phage genome is destroyed prior to expression of the acr gene, with no change in bacterial
resistance (i.e. no immunosuppression). Hence, r is a measure of bacterial resistance and increases with the number of
spacers targeting the phage. We assume r is governed by the host and independent of the Acr.
(ii) with probability (1  r)4,the Acr-positive phage lyses the cell, with the release of B new Acr-positive phage particles. Hence,
the greater 4, the greater is the ability of the Acr-positive phage to bypass the CRISPR-Cas immune system.
(iii) with probability (1 r)(1 4), the Acr-positive phage fails to complete its lytic cycle but produces some Acr proteins before its
genome is cleaved, which block bacterial CRISPR-resistance and cause the bacterium to become immunosuppressed. This
state is reversible and immunosuppressed bacterium become resistant again at rate g. Hence, the smaller g, the longer the
bacterium remains in the immunosuppressed state.
If an immunosuppressed bacterium is infected by a phage, the absence of resistance allows the phage to complete its lytic cycle,
even if it does not encode an Acr. This yields the following set of ordinary differential equations (see Figure 5A):
_WðtÞ = rWðtÞð1 kNðtÞÞ  ðaV1ðtÞ + aV2ðtÞ + mÞWðtÞ_RðtÞ = AaVðtÞWðtÞ+ rRðtÞð1 kNðtÞÞ  ða ð1 rÞV1ðtÞ + mÞRðtÞ+gSðtÞ_SðtÞ = að1 rÞð14ÞV1ðtÞRðtÞ  ða VðtÞ + m + gÞSðtÞ_V1ðtÞ = að1 rÞ4B V1ðtÞRðtÞ+ aB V1ðtÞðSðtÞ + ð1AÞWðtÞÞ  a NðtÞV1ðtÞ_V2ðtÞ = aB V2ðtÞðSðtÞ + ð1AÞWðtÞÞ  a NðtÞV2ðtÞ
With NðtÞ=WðtÞ+RðtÞ+SðtÞ, and VðtÞ=V1ðtÞ+V2ðtÞ.
We used the above model to monitor the infection dynamics following infection with an equal mix of Acr-positive phages (V1) and
Acr-negative phages (V2) that cannot infect resistant bacteria, with different parameter values 4 and g, reflecting different strength of
Acr. All the parameter values are given in the legends of related figures.Cell Host & Microbe 27, 1–10.e1–e6, February 12, 2020 e5
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All graphs of experimental data and statistical analyses were generated with GraphPad Prism 7. Statistical details of experiments are
indicated in the figure legends. After verifying that the data (log-transformed when appropriate) were not inconsistent with a Gaussian
distribution (Shapiro-Wilk normality test), one-tailed t-tests were used to determine whether experimental values (i.e. relative fitness
or phage amplification) significantly differed from a theoretical value (e.g. 1), and two-tailed unpaired t-tests were used to compare
groups with each other, where appropriate. Each group was composed of 6 values (i.e. 6 independent biological replicates) and 95%
confidence levels were used in all statistical tests. In all cases, observed differences were considered significant when p-values were
less than a Bonferroni-corrected threshold of 0.05/a, where a is the number of comparisons.
DATA AND CODE AVAILABILITY
The accession number for the amplicon sequencing data reported in this paper is ENA: PRJEB29041. Source data for Figures 1, 2, 3,
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